Biotech unicorn Oxford Nanopore Technologies has raised £195 million in new capital
Oxford Nanopore Technologies, a next generation DNA/RNA sequencing technology company, recently has raise £195 million in new capital in a private transaction. £125 million of the investment comes from new investors Temasek, Wellington Management, M&G Investments and Nikon. In addition, existing shareholders invested £70 million.
About Oxford Nanopore Technologies
Founded in 2005 as a spin-out from the University of Oxford, Oxford Nanopore Technologies has developed a new generation of DNA/RNA sequencing technology. It is the only sequencing technology that offers real-time analysis, in fully scalable formats from pocket to population scale, that can analyse native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths.